Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Geron Corporation    GERN   US3741631036

GERON CORPORATION (GERN)

16
Delayed Quote. Delayed Nasdaq - 07/28 10:07:30 am
2.42 USD   --.--%
6d ago GERON CORPORATION : Spin off
7d ago GERON : Other Events (form 8-K)
06/13 GERON : GERN) Gains After FDA Green Lights Imetelstat Trial Resumption
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/22/2014 07/23/2014 07/24/2014 07/25/2014 07/28/2014 Date
2.59(c) 2.53(c) 2.53(c) 2.42(c) 2.42 Last
3 279 921 5 425 965 2 950 480 2 495 587 393 454 Volume
-4.78% -2.32% 0.00% -4.35% 0.00% Change
More quotes
Company
Geron Corp. discovers and develops therapeutic products for cancer. It is a clinical stage biopharmaceutical company developing a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The company's imetelstat, their sole product candidate, is a potent and specific inhibitor of... 
Surperformance© rating of Geron Corporation
Trading Rating : Investor Rating :
More about the company
Chart GERON CORPORATION
Duration : Period :
Geron Corporation Technical Analysis Chart | GERN | US3741631036 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 1,32 M
EBIT 2014 -37,4 M
Net income 2014 -37,6 M
Debt 2014 -
Yield 2014 -
Sales 2015 1,66 M
EBIT 2015 -40,9 M
Net income 2015 -41,5 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 287x
Capi. / Sales 2015 228x
Capitalization 380 M
More Financials
Latest news on GERON CORPORATION
6d ago GERON CORPORATION : Spin off
7d ago GERON : Other Events (form 8-K)
06/13 GERON : GERN) Gains After FDA Green Lights Imetelstat Trial Resumption
06/13 GERON : GERN) (Biotech Winner of Day)
06/12 Wall St. slides on concerns about Iraq
06/12DJU.S. HOT STOCKS : Hot Stocks to Watch
06/12 GERON : Reports Removal of Partial Clinical Hold on Myelofibrosis IST
06/12 GERON : Other Events, Financial Statements and Exhibits (form 8-K)
06/04 GERON : ViaCyte and Asterias Biotherapeutics Settle Patent Dispute
06/02 GERON : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
05/30 GERON : Stocks Coverage on Biotech Equities -- Research on Gilead Sciences, ARIA..
05/29 GERON : "Synthetic Surfaces for Culturing Stem Cell Derived Oligodendrocyte Prog..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
Geron Corporation : Income Statement Evolution
More Financials
EPS Revisions
Geron Corporation : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF